Flavonoid quercetin decreases osteoclastic differentiation induced by RANKL via a mechanism involving NFκB and AP-1

Journal of Cellular Biochemistry

Volumn 92, Issue 2, 2004, Pages 285-295

  Wattel, Alice ^a   Kamel, Said ^a   Prouillet, Christophe ^a   Petit, Jean Pierre ^a   Lorget, Florence ^b   Offord, Elizabeth ^b   Brazier, Michel ^a  

^a UNIVERSITÉ DE PICARDIE JULES VERNE   (France)

^b NESTLÉ RESEARCH CENTER   (Switzerland)

Author keywords

AP 1; Bone resorption; Differentiation; Flavonoids; NF N; Osteoclast; Quercetin

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; COLONY STIMULATING FACTOR 1; FLAVONOID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; OSTEOCLAST DIFFERENTIATION FACTOR; QUERCETIN; TRANSCRIPTION FACTOR AP 1; CARRIER PROTEIN; MEMBRANE PROTEIN; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; TNFRSF11A PROTEIN, HUMAN; TNFRSF11A PROTEIN, MOUSE; TNFSF11 PROTEIN, HUMAN; TNFSF11 PROTEIN, MOUSE;

ANIMAL CELL; ARTICLE; BIOLOGICAL MODEL; CELL DIFFERENTIATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG INHIBITION; GEL MOBILITY SHIFT ASSAY; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; OSTEOCLAST; OSTEOLYSIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DNA INTERACTION; ANIMAL; CELL LINE; CYTOLOGY; DRUG EFFECT; METABOLISM; MOUSE;

ANIMALIA; MURINAE;

ANIMALS; CARRIER PROTEINS; CELL DIFFERENTIATION; CELL LINE; HUMANS; MEMBRANE GLYCOPROTEINS; MICE; NF-KAPPA B; OSTEOCLASTS; QUERCETIN; RANK LIGAND; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B; TRANSCRIPTION FACTOR AP-1;

EID: 8844234806     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.20071     Document Type: Article

References (47)

1. Anderson JJ, Garner SC. 1998. Phytoestrogens and bone. Baillieres Clin Endocrinol Metab 12:543-557.
2. Battaglino R, Kim D, Fu J, Vaage B, Fu XY, Stashenko P. 2002. C-myc is required for osteoclast differentiation. J Bone Miner Res 17:763-773.
3. Bax BE, Alam AS, Banerji B, Bax CM, Bevis PJ, Stevens CR, Moonga RS; Blake DR, Zaidi M. 1992. Stimulation of osteoclastic bone resorption by hydrogen peroxide. Biochem Biophys Res Commun 183:1153-1158.
4. Chiba H, Uehara M, Wu J, Wang X, Masuyama R, Suzuki K, Kanazawa K, Ishimi Y. 2003. Hesperidin, a citrus flavonoid, inhibits bone loss and decreases serum and hepatic lipids in ovariectomized mice. J Nutr 133:1892-1897.
5. Darnay BG, Haridas V, Ni J, Moore PA, Aggarwal BB. 1998. Characterization of the intracellular domain of receptor activator of NF-kappaB (RANK). Interaction with tumor necrosis factor receptor-associated factors and activation of NF-kappab and c-Jun N-terminal kinase. J Biol Chem 273:20551-20555.
6. de Vries JH, Janssen PL, Hollman PC, van Staveren WA, Katan MB. 1997. Consumption of quercetin and kaempferol in free-living subjects eating a variety of diets. Cancer Lett 114:141-144.
7. Grigoriadis AE, Wang ZQ, Cecchini MG, Hofstetter W, Felix R, Fleisch HA, Wagner EF. 1994. C-Fos: A key regulator of osteoclast-macrophage lineage determination and bone remodeling. Science 266:443-448.
8. Hall TJ, Schaeublin M, Jeker H, Fuller K, Chambers TJ. 1995. The role of reactive oxygen intermediates in osteoclastic bone resorption. Biochem Biophys Res Commun 207:280-287.
9. Hegarty VM, May HM, Khaw KT. 2000. Tea drinking and bone mineral density in older women. Am J Clin Nutr 71:1003-1007.
10. Hollman PC, van Trijp JM, Buysman MN, van der Gaag MS, Mengelers MJ, de Vries JH, Katan MB. 1997. Relative bioavailability of the antioxidant flavonoid quercetin from various foods in man. FEBS Lett 418: 152-156.
11. Horcajada-Molteni MN, Crespy V, Coxam V, Davicco MJ, Remesy C, Barlet JP. 2000. Rutin inhibits ovariectomy-induced osteopenia in rats. J Bone Miner Res 15:2251-2258.
12. Hotokezaka H, Sakai E, Kanaoka K, Saito K, Matsuo K, Kitaura H, Yoshida N, Nakayama K. 2002. U0126 and PD98059, specific inhibitors of MEK, accelerate differentiation of RAW264.7 cells into osteoclast-like cells. J Biol Chem 277:47366-47372.
13. Hsu H, Lacey DL, Dunstan CR, Solovyev I, Colombero A, Timms E, Tan HL, Elliott G, Kelley MJ, Sarosi I, Wang L, Xia XZ, Elliott R, Chiu L, Black T, Scully S, Capparelli C, Morony S, Shimamoto G, Bass MB, Boyle WJ. 1999. Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand. Proc Natl Acad Sci USA 96:3540-3545.
14. Iotsova V, Caamano J, Loy J, Yang Y, Lewin A, Bravo R. 1997. Osteopetrosis in mice lacking NF-kappaB1 and NF-kappaB2. Nat Med 3:1285-1289.
15. Ishikawa Y, Kitamura M. 2000. Anti-apoptotic effect of quercetin: Intervention in the JNK- and ERK-mediated apoptotic pathways. Kidney Int 58:1078-1087.
16. Ishikawa Y, Sugiyama H, Stylianou E, Kitamura M. 1999. Bioflavonoid quercetin inhibits interleukin-1-induced transcriptional expression of monocyte chemoattractant protein-1 in glomerular cells via suppression of nuclear factor-kappaB. J Am Soc Nephrol 10:2290-2296.
17. Jimi E, Nakamura I, Ikebe T, Akiyama S, Takahashi N, Suda T. 1998. Activation of NF-kappaB is involved in the survival of osteoclasts promoted by interleukin-1. J Biol Chem 273:8799-8805.
18. Jung JY, Lin AC, Ramos LM, Faddis BT, Chole RA. 2003. Nitric oxide synthase I mediates osteoclast activity in vitro and in vivo. J Cell Biochem 89:613-621.
19. Kimira M, Arai Y, Shimoi K, Watanabe S. 1998. Japanese intake of flavonoids and isoflavonoids from foods. J Epidemiol 8:168-175.
20. Kyaw M, Yoshizumi M, Tsuchiya K, Kirima K, Suzaki Y, Abe S, Hasegawa T, Tamaki T. 2002. Antioxidants inhibit endothelin-1 (l-31)-induced proliferation of vascular smooth muscle cells via the inhibition of mitogen-activated protein (MAP) kinase and activator protein-1 (AP-1). Biochem Pharmacol 64:1521-1531.
21. 2-terminal kinases. J Biol Chem 271:15703-15707.
22. Lorget F, Mentaverri R, Meddah B, Cayrolle G, Wattel A, Morel A, Schecroun N, Maamer M, De Vernejoul MC, Kamel S, Brazier M. 2000. Evaluation of in vitro bone resorption: High-performance liquid chromatography measurement of the pyridinolines released in osteoclast cultures. Anal Biochem 284:375-381.
23. Lorget F, Clough J, Oliveira M, Daury MC, Sabokbar A, Offord E. 2002. Lactoferrin reduces in vitro osteoclast differentiation and resorbing activity. Biochem Biophys Res Commun 296:261-266.
24. Matsuo K, Owens JM, Tonko M, Elliott C, Chambers TJ, Wagner EF. 2000. Fosl1 is a transcriptional target of c-Fos during osteoclast differentiation. Nat Genet 24: 184-187.
25. Matsuzaki K, Udagawa N, Takahashi N, Yamaguchi K, Yasuda H, Shima N, Morinaga T, Toyama Y, Yabe Y, Higashio K, Suda T. 1998. Osteoclast differentiation factor (ODF) induces osteoclast-like cell formation in human peripheral blood mononuclear cell cultures. Biochem Biophys Res Commun 246:199-204.
26. Moon JH, Nakata R, Oshima S, Inakuma T, Terao J. 2000. Accumulation of quercetin conjugates in blood plasma after the short-term ingestion of onion by women. Am J Physiol Regul Integr Comp Physiol 279:R461-R467.
27. Morabito N, Crisafulli A, Vergara C, Gaudio A, Lasco A, Frisina N, D'Anna R, Corrado F, Pizzoleo MA, Cincotta M, Altavilla D, Ientile R, Squadrito F. 2002. Effects of genistein and hormone-replacement therapy on bone loss in early postmenopausal women: A randomized double-blind placebo-controlled study. J Bone Miner Res 17:1904-1912.
28. Muhlbauer RC, Li F. 1999. Effect of vegetables on bone metabolism. Nature 23:343-344.
29. Muhlbauer RC, Lozano A, Reinli A. 2002. Onion and a mixture of vegetables, salads, and herbs affect bone resorption in the rat by a mechanism independent of their base excess. J Bone Miner Res 17:1230-1236.
30. New SA, Robins SP, Campbell MK, Martin JC, Carton MJ, Bolton-Smith C, Grubb DA, Lee SJ, Reid DM. 2000. Dietary influences on bone mass and bone metabolism: Further evidence of a positive link between fruit and vegetable consumption and bone health? Am J Clin Nutr 71:142-151.
31. Nijveldt RJ, Van Nood E, van Hoorn DE, Boelens PG, Van Norren K, Van Leeuwen PA. 2001. Flavonoids: A review of probable mechanisms of action and potential applications. Am J Clin Nutr 74:418-425.
32. Quinn JM, Itoh K, Udagawa N, Hausler K, Yasuda H, Shima N, Mizuno A, Higashio K, Takahashi N, Suda T, Martin TJ, Gillespie MT. 2001. Transforming growth factor beta affects osteoclast differentiation via direct and indirect actions. J Bone Miner Res 16:1787-1794.
33. Rassi CM, Lieberherr M, Chaumaz G, Pointillart A, Cournot G. 2002. Down-regulation of osteoclast differentiation by daidzein via caspase 3. J Bone Miner Res 17:630-638.
34. Rice-Evans CA, Miller NJ, Bolwell PG, Bramley PM, Pridham JB. 1995. The relative antioxidant activities of plant-derived polyphenolic flavonoids. Free Radic Res 22:375-383.
35. Schreck R, Rieber P, Baeuerle PA. 1991. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1. EMBO J 10:2247-2258.
36. Setchell KD, Cassidy A. 1999. Dietary isoflavones: Biological effects and relevance to human health. J Nutr 129:758-767.
37. Shalhoub V, Elliott G, Chiu L, Manoukian R, Kelley M, Hawkins N, Davy E, Shimamoto G, Beck J, Kaufman SA, Van G, Scully S, Qi M, Grisanti M, Dunstan C, Boyle WJ, Lacey DL. 2000. Characterization of osteoclast precursors in human blood. Br J Haematol 111:501-512.
38. Shevde NK, Bendixen AC, Dienger KM, Pike JW. 2000. Estrogens suppress RANK ligand-induced osteoclast differentiation via a stromal cell independent mechanism involving c-Jun repression. Proc Natl Acad Sci USA 97:7829-7834.
39. Srivastava S, Toraldo G, Weitzmann MN, Cenci S, Ross FP, Pacifici R. 2001. Estrogen decreases osteoclast formation by down-regulating receptor activator of NF-kappa B ligand (RANKL)-induced JNK activation. J Biol Chem 276:8836-8840.
40. Suda N, Morita I, Kuroda T, Murota S. 1993. Participation of oxidative stress in the process of osteoclast differentiation. Biochim Biophys Acta 1157:318-323.
41. Tucker KL, Hannan MT, Chen H, Cupples LA, Wilson PW, Kiel DP. 1999. Potassium, magnesium, and fruit and vegetable intakes are associated with greater bone mineral density in elderly men and women. Am J Clin Nutr 69:727-736.
42. van't Hof RJ, Armour KJ, Smith LM, Armour KE, Wei XQ, Liew FY, Ralston SH. 2000. Requirement of the inducible nitric oxide synthase pathway for IL-1-induced osteoclastic bone resorption. Proc Natl Acad Sci USA 97:7993-7998.
43. Wattel A, Kamel S, Mentaverri R, Lorget F, Prouillet C, Petit JP, Fardelonne P, Brazier M. 2003. Potent inhibitory effect of naturally occurring flavonoids quercetin and kaempferol on in vitro osteoclastic bone resorption. Biochem Pharmacol 65:35-42.
44. Wei S, Teitelbaum SL, Wang MW, Ross FP. 2001. Receptor activator of nuclear factor-kappa b ligand activates nuclear factor-kappa b in osteoclast precursors. Endocrinology 142:1290-1295.
45. Wolle J, Ferguson E, Keshava C, Devall LJ, Boschelli DH, Newton RS, Saxena U. 1995. Inhibition of tumor necrosis factor induced human aortic endothelial cell adhesion molecule gene expression by an alkoxybenzo[b] thiophene-2-carboxamide. Biochem Biophys Res Commun 214:6-10.
46. Yamagishi T, Otsuka E, Hagiwara H. 2001. Reciprocal control of expression of mRNAs for osteoclast differentiation factor and OPG in osteogenic stromal cells by genistein: Evidence for the involvement of topoisomerase II in osteoclastogenesis. Endocrinology 142:3632-3637.
47. Ye H, Arron JR, Lamothe B, Cirilli M, Kobayashi T, Shevde NK, Segal D, Dzivenu OK, Vologodskaia M, Yim M, Du K, Singh S, Pike JW, Darnay BG, Choi Y, Wu H. 2002. Distinct molecular mechanism for initiating TRAF6 signalling. Nature 418:443-447.